When the Federal Circuit denied the Request for Panel Rehearing and Rehearing en banc in In re Baxter, the court let stand its two decisions that affirmed conflicting rulings on the validity of the same patent. In Fresenius USA, Inc. v. Baxter Int’l, Inc., 582 F.3d 1288 (Fed. Cir. 2009), the court affirmed the district court decision that upheld the validity of claims 26-31 of U.S. Patent 5,247,434, while in its May 17, 2012 decision in In re Baxter, the court affirmed the USPTO Board decision that the claims were invalid as obvious. Parallel litigation and USPTO proceedings involving the same patent may become more rare now that the America Invents Act (AIA) has replaced inter partes reexamination with inter partes review and placed restrictions on parallel litigation proceedings, but still could arise from pending inter partes reexamination proceedings or from ex parte reexamination proceedings, which are not subject to the same restrictions.Continue reading this entry
Tag Archives: Res Judicata
Subscribe to This Blog
Topics
- 101
- 102
- 103
- Bilski
- Biosimilars
- Claim Construction
- District Court Decisions
- Doctrine of Equivalents
- Duty of Disclosure
- Enablement
- Federal Circuit Decisions
- Inequitable Conduct
- Infringement
- International Patent Practice
- Life Sciences Agreements
- Myriad
- Obviousness Type Double Patenting
- Patent Office Practice
- Patent Reform
- Patent Term Adjustment
- Patent Term Extension
- Patent Trials
- Personalized Medicine
- Prometheus
- Reasonable Royalty
- Reexam
- Supreme Court Decisions
- Uncategorized
- USPTO Board Decisions
- USPTO Proposed Rule Changes
- Written Description
Recent Updates
- In Uship Federal Circuit Finds Prosecution History Disclaimer In Arguments Against Restriction Requirement
- USPTO Launches New After Final Consideration Pilot Program To Reduce Requests For Continued Examination (RCEs)
- Supreme Court Finds For Monsanto In Seed Harvesting Case
- Federal Circuit Issues Fractured Affirmance In CLS Bank v. Alice Corporation
- USPTO Reshuffles The RCE Deck
Twitter Updates
@PharmaPatents PharmaPatents' Recent Twitter Posts
- New article: In Uship Federal Circuit Finds Prosecution History Disclaimer In Arguments Against http://t.co/ZWwyw7UQGA ##patent
(about 14 hours ago) - RT @LXBN: USPTO Launches New After Final Consideration Pilot Program To Reduce Requests f/ Continued Examination http://t.co/0wZkObsUp6 @Ph…
(about 2 days ago) - New article: USPTO Launches New After Final Consideration Pilot Program To Reduce Requests For http://t.co/ftDOBYcEgK ##patent
(about 3 days ago) - RT @LXBN: Supreme Court Finds For Monsanto In Seed Harvesting Case http://t.co/otl9Pbs0Q2 - @PharmaPatents
(about 6 days ago) - RT @priorsmart: Just read: Supreme Court Finds For Monsanto In Seed Harvesting Case - http://t.co/70U6m8vVvw [at @pharmapatents] #patent
(about 7 days ago)